Line 1: | Line 1: | ||
{{Hannover}} | {{Hannover}} | ||
<html> | <html> | ||
+ | <head> | ||
+ | <link rel="stylesheet" type="text/css" | ||
+ | href="https://2016.igem.org/Template:Team:Hannover/CSS?action=raw&ctype=text/css" /> | ||
+ | </head> | ||
+ | <body> | ||
− | + | <div class="container-fluid text-center"> | |
− | + | <div class="row content" style="background-color:rgb(0, 107, 168);"> | |
− | <div class=" | + | <div class="col-sm-2 sidenav"> |
+ | <div class="panel-group" style="text-align: left;"> | ||
+ | <div class="panel panel-default"> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" href="#collapseMenu"><strong>Projects</strong></a> | ||
+ | </h4> | ||
+ | <div id="collapseMenu" class="panel-collapse collapse in"> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" href="#collapseTALebots"><strong>TALebots</strong></a> | ||
+ | </h4> | ||
+ | </div> | ||
+ | <div id="collapseTALebots" class="panel-collapse collapse in"> | ||
+ | <ul class="list-group"> | ||
+ | <li>Description</li> | ||
+ | <li>Design</li> | ||
+ | <li>Modelling</li> | ||
+ | <li>Proof</li> | ||
+ | <li>Demonstrate</li> | ||
+ | <li>Results</li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" href="#collapseSW"><strong>Software Tools</strong></a> | ||
+ | </h4> | ||
+ | </div> | ||
+ | <div id="collapseSW" class="panel-collapse collapse in"> | ||
+ | <ul class="list-group"> | ||
+ | <li>Description</li> | ||
+ | <li>Design</li> | ||
+ | <li>Modelling</li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" href="#collapseInterLab"><strong>InterLab Study</strong></a> | ||
+ | </h4> | ||
+ | </div> | ||
+ | <div id="collapseInterLab" class="panel-collapse collapse in"> | ||
+ | <ul class="list-group"> | ||
+ | <li>Results</li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-sm-8 text-left main-content"> | ||
+ | <h1>Description</h1> | ||
+ | (Improving a previous iGEM project) | ||
<h3>★ Enable the usage of TAL-effector proteins in-vitro </h3> | <h3>★ Enable the usage of TAL-effector proteins in-vitro </h3> | ||
<p>TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions. | <p>TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions. | ||
Line 14: | Line 71: | ||
Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab. | Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab. | ||
</p> | </p> | ||
+ | |||
+ | </div> | ||
+ | <div class="col-sm-2 sidenav"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/7/72/T--Hannover--background.png" class="background-img"/> | ||
+ | </div> | ||
+ | </div> | ||
</div> | </div> | ||
− | + | <footer class="container-fluid text-center"> | |
+ | <h5>Sponsors</h5> | ||
+ | <p><small><strong>Our project would not have been possible without financial support from multiple sponsors and supporters.</strong> | ||
+ | <img class="sponsorImg" src="TODO" alt="Carl Roth"> | ||
+ | <img class="sponsorImg" src="TODO" alt="IDT"> | ||
+ | <img class="sponsorImg" src="TODO" alt="Leibniz University Hannover "> | ||
+ | <img class="sponsorImg" src="TODO" alt="Leibniz Universitätsgesellschaft e.V. "> | ||
+ | <img class="sponsorImg" src="TODO" alt="New England Biolabs "> | ||
+ | <img class="sponsorImg" src="TODO" alt="Promega"> | ||
+ | <img class="sponsorImg" src="TODO" alt="Sartorius"> | ||
+ | <img class="sponsorImg" src="TODO" alt="SnapGene"> | ||
+ | </small></p> | ||
+ | </footer> | ||
+ | </body> | ||
</html> | </html> |
Revision as of 20:06, 13 October 2016
Projects
- Description
- Design
- Modelling
- Proof
- Demonstrate
- Results
- Description
- Design
- Modelling
- Results
Description
(Improving a previous iGEM project)★ Enable the usage of TAL-effector proteins in-vitro
TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions.
Originally, those proteins were discovered in Xanthomonas. Those bacteria use TAL-effectors to specifically regulate host genes. After decoding the amino-acid-code of TAL-effectors, genetic changes can be generated. In this way, DNA-fragments can be replaced and precisely cut or foreign DNA can be inserted.
TAL-effector proteins offer a significant advantage compared to usual procedures e.g. with restriction enzymes: Trough an easy change of the amino acid sequence, the protein can be customized to any DNA sequence. The function of TAL-effectors could be proven in vivo in cell cultures and also in animals. However, they show a high instability outside living organisms. This instability leads to the problem that the purification of TAL-effectors as well as the in-vitro application in the lab is difficult to perform. For this reason, TAL-effector proteins are excluded from a huge field of application, because a lot of genetic work usually takes place “in test tubes”.
Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab.